Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply
Are you familiar with the AETC Program HIV Care Tools App?
Image
graphic image

(Recorded on 1/12/2026)

Long-acting antiretrovirals are now becoming mainstream for the management of people with HIV who are virologically suppressed or for those with drug resistance and limited treatment options. Furthermore, long-acting ART has shown promise to improve treatment outcomes for individuals struggling with adherence to daily oral ART. Data on the currently approved long-acting ART for HIV treatment along with real-world evidence and implementation challenges is the focus of this lecture.

Speaker

Onyema Ogbuagu, MBBCh, FACP, FIDSA
Associate Professor of Medicine (AIDS) and of Pharmacology